{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T18:34:20Z","timestamp":1793385260327,"version":"4.5.0"},"reference-count":130,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T00:00:00Z","timestamp":1750204800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T00:00:00Z","timestamp":1750204800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Tai\u2019an City Science and Technology Innovation Development Project","award":["2018NS0221"],"award-info":[{"award-number":["2018NS0221"]}]},{"name":"Tai\u2019an City Science and Technology Innovation Development Project","award":["2022NS260"],"award-info":[{"award-number":["2022NS260"]}]},{"name":"Nursery Project of the Affiliated Tai'an City Central Hospital of Qingdao University","award":["2022MPM22"],"award-info":[{"award-number":["2022MPM22"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"DOI":"10.1186\/s40001-025-02694-1","type":"journal-article","created":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T05:09:52Z","timestamp":1750223392000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["The PD-1\/PD-L1 pathway and Epstein\u2013Barr virus"],"prefix":"10.1186","volume":"30","author":[{"given":"Hui","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongshuang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cundong","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youzhen","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Mi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,18]]},"reference":[{"issue":"5","key":"2694_CR1","doi-asserted-by":"publisher","first-page":"e64921","DOI":"10.1371\/journal.pone.0064921","volume":"8","author":"JB Dowd","year":"2013","unstructured":"Dowd JB, Palermo T, Brite J, McDade TW, Aiello A. Seroprevalence of Epstein\u2013Barr virus infection in U.S. children ages 6\u201319, 2003\u20132010. PLoS ONE. 2013;8(5):e64921.","journal-title":"PLoS ONE"},{"issue":"1408","key":"2694_CR2","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1098\/rstb.2000.0783","volume":"356","author":"DH Crawford","year":"2001","unstructured":"Crawford DH. Biology and disease associations of Epstein\u2013Barr virus. Philos Trans R Soc Lond B Biol Sci. 2001;356(1408):461\u201373.","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"issue":"23","key":"2694_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1017\/S1462399404008440","volume":"6","author":"EK Vetsika","year":"2004","unstructured":"Vetsika EK, Callan M. Infectious mononucleosis and Epstein\u2013Barr virus. Expert Rev Mol Med. 2004;6(23):1\u201316.","journal-title":"Expert Rev Mol Med"},{"issue":"3","key":"2694_CR4","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1128\/microbiolspec.DMIH2-0011-2015","volume":"4","author":"A Nowalk","year":"2016","unstructured":"Nowalk A, Green M. Epstein\u2013Barr virus. Microbiol Spectr. 2016;4(3):10\u2013128.","journal-title":"Microbiol Spectr"},{"issue":"1","key":"2694_CR5","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/1750-9378-9-38","volume":"9","author":"G Khan","year":"2014","unstructured":"Khan G, Hashim M. Global burden of deaths from Epstein\u2013Barr virus attributable malignancies 1990\u20132010. Infect Agent Cancer. 2014;9(1):38.","journal-title":"Infect Agent Cancer"},{"issue":"5","key":"2694_CR6","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1038\/s41588-018-0102-3","volume":"50","author":"JB Harley","year":"2018","unstructured":"Harley JB, Chen X, Pujato M, Miller D, Maddox A, Forney C, Magnusen AF, Lynch A, Chetal K, Yukawa M, Barski A, Salomonis N, Kaufman KM, Kottyan LC, Weirauch MT. Transcription factors operate across disease loci, with EBNA2 implicated in autoimmunity. Nat Genet. 2018;50(5):699\u2013707.","journal-title":"Nat Genet"},{"issue":"02","key":"2694_CR7","doi-asserted-by":"publisher","first-page":"B194","DOI":"10.1016\/j.vaccine.2012.09.041","volume":"31","author":"JI Cohen","year":"2013","unstructured":"Cohen JI, Mocarski E, Raab-Traub N, Corey L, Nabel GJ. The need and challenges for development of an Epstein\u2013Barr virus vaccine. Vaccine. 2013;31(02):B194\u20136.","journal-title":"Vaccine"},{"issue":"12","key":"2694_CR8","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1086\/523813","volume":"196","author":"EM Sokal","year":"2007","unstructured":"Sokal EM, Hoppenbrouwers K, Vandermeulen C, Moutschen M, L\u00e9onard P, Moreels A, Haumont M, Bollen A, Smets F, Denis M. Recombinant gp350 vaccine for infectious mononucleosis: a phase 2, randomized, double-blind, placebo-controlled trial to evaluate the safety, immunogenicity, and efficacy of an Epstein\u2013Barr virus vaccine in healthy young adults. J Infect Dis. 2007;196(12):1749\u201353.","journal-title":"J Infect Dis"},{"issue":"8","key":"2694_CR9","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1038\/nm0896-906","volume":"2","author":"MF Callan","year":"1996","unstructured":"Callan MF, Steven N, Krausa P, Wilson JD, Moss PA, Gillespie GM, Bell JI, Rickinson AB, McMichael AJ. Large clonal expansions of CD8+ T cells in acute infectious mononucleosis. Nat Med. 1996;2(8):906\u201311.","journal-title":"Nat Med"},{"issue":"3","key":"2694_CR10","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/S1040-8428(02)00112-9","volume":"44","author":"S Ohga","year":"2002","unstructured":"Ohga S, Nomura A, Takada H, Hara T. Immunological aspects of Epstein\u2013Barr virus infection. Crit Rev Oncol Hematol. 2002;44(3):203\u201315.","journal-title":"Crit Rev Oncol Hematol"},{"issue":"3","key":"2694_CR11","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1182\/blood.V85.3.744.bloodjournal853744","volume":"85","author":"I Anagnostopoulos","year":"1995","unstructured":"Anagnostopoulos I, Hummel M, Kreschel C, Stein H. Morphology, immunophenotype, and distribution of latently and\/or productively Epstein\u2013Barr virus-infected cells in acute infectious mononucleosis: implications for the interindividual infection route of Epstein\u2013Barr virus. Blood. 1995;85(3):744\u201350.","journal-title":"Blood"},{"issue":"12","key":"2694_CR12","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1038\/nrmicro3135","volume":"11","author":"PM Lieberman","year":"2013","unstructured":"Lieberman PM. Keeping it quiet: chromatin control of gammaherpesvirus latency. Nat Rev Microbiol. 2013;11(12):863\u201375.","journal-title":"Nat Rev Microbiol"},{"issue":"6","key":"2694_CR13","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1007\/s00705-017-3278-4","volume":"162","author":"Z Zhao","year":"2017","unstructured":"Zhao Z, Sun L, Liu S, Shu J, Luo B. Characterization of Epstein\u2013Barr virus-encoded small RNA gene variations in virus associated lymphomas in Northern China. Arch Virol. 2017;162(6):1609\u201316.","journal-title":"Arch Virol"},{"key":"2694_CR14","doi-asserted-by":"publisher","first-page":"107025","DOI":"10.1016\/j.micpath.2024.107025","volume":"197","author":"P Mahdavi","year":"2024","unstructured":"Mahdavi P, Javaherdehi AP, Khanjanpoor P, Aminian H, Zakeri M, Zafarani A, Razizadeh MH. The role of c-Myc in Epstein\u2013Barr virus-associated cancers: mechanistic insights and therapeutic implications. Microb Pathog. 2024;197:107025.","journal-title":"Microb Pathog"},{"key":"2694_CR15","doi-asserted-by":"publisher","first-page":"713","DOI":"10.3389\/fonc.2019.00713","volume":"9","author":"C Shannon-Lowe","year":"2019","unstructured":"Shannon-Lowe C, Rickinson A. The global landscape of EBV-associated tumors. Front Oncol. 2019;9:713.","journal-title":"Front Oncol"},{"key":"2694_CR16","doi-asserted-by":"publisher","first-page":"109","DOI":"10.3389\/fonc.2019.00109","volume":"9","author":"JL Crombie","year":"2019","unstructured":"Crombie JL, LaCasce A. Epstein Barr virus associated B-cell lymphomas and iatrogenic lymphoproliferative disorders. Front Oncol. 2019;9:109.","journal-title":"Front Oncol"},{"issue":"1","key":"2694_CR17","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1186\/s12887-024-05228-6","volume":"24","author":"J Zhou","year":"2024","unstructured":"Zhou J, Zhang J, Zhu D, Ma W, Zhong Q, Shen Q, Su J. The diagnostic value of peripheral blood lymphocyte testing in children with infectious mononucleosis. BMC Pediatr. 2024;24(1):746.","journal-title":"BMC Pediatr"},{"issue":"10","key":"2694_CR18","doi-asserted-by":"publisher","first-page":"e29960","DOI":"10.1002\/jmv.29960","volume":"96","author":"B Ding","year":"2024","unstructured":"Ding B, Zhang Y, Wu Y, Li Y. Analysis of the epidemiology and clinical characteristics of Epstein\u2013Barr virus infection. J Med Virol. 2024;96(10):e29960.","journal-title":"J Med Virol"},{"issue":"21","key":"2694_CR19","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1056\/NEJMcp1001116","volume":"362","author":"K Luzuriaga","year":"2010","unstructured":"Luzuriaga K, Sullivan J. Infectious mononucleosis. N Engl J Med. 2010;362(21):1993\u20132000.","journal-title":"N Engl J Med"},{"issue":"7","key":"2694_CR20","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1056\/NEJM200008173430707","volume":"343","author":"JI Cohen","year":"2000","unstructured":"Cohen JI. Epstein\u2013Barr virus infection. N Engl J Med. 2000;343(7):481\u201392.","journal-title":"N Engl J Med"},{"issue":"16","key":"2694_CR21","doi-asserted-by":"publisher","first-page":"2533","DOI":"10.1182\/blood-2014-01-553024","volume":"124","author":"T Azzi","year":"2014","unstructured":"Azzi T, L\u00fcnemann A, Murer A, Ueda S, B\u00e9ziat V, Malmberg KJ, Staubli G, Gysin C, Berger C, M\u00fcnz C, Chijioke O, Nadal D. Role for early-differentiated natural killer cells in infectious mononucleosis. Blood. 2014;124(16):2533\u201343.","journal-title":"Blood"},{"issue":"15","key":"2694_CR22","first-page":"1486","volume":"363","author":"K Luzuriaga","year":"2010","unstructured":"Luzuriaga K, Sullivan J. Infectious mononucleosis [published correction appears in N Engl J Med. N Engl J Med. 2010;363(15):1486.","journal-title":"N Engl J Med"},{"key":"2694_CR23","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.3389\/fimmu.2017.01867","volume":"8","author":"H Kimura","year":"2017","unstructured":"Kimura H, Cohen J. Chronic active Epstein\u2013Barr virus disease. Front Immunol. 2017;8:1867.","journal-title":"Front Immunol"},{"issue":"11","key":"2694_CR24","doi-asserted-by":"publisher","first-page":"3802","DOI":"10.4049\/jimmunol.139.11.3802","volume":"139","author":"BE Tomkinson","year":"1987","unstructured":"Tomkinson BE, Wagner D, Nelson DL, Sullivan JL. Activated lymphocytes during acute Epstein\u2013Barr virus infection. J Immunol. 1987;139(11):3802\u20137.","journal-title":"J Immunol"},{"issue":"17","key":"2694_CR25","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1056\/NEJM199404283301703","volume":"330","author":"EB Papadopoulos","year":"1994","unstructured":"Papadopoulos EB, Ladanyi M, Emanuel D, Mackinnon S, Boulad F, Carabasi MH, Castro-Malaspina H, Childs BH, Gillio AP, Small TN. Infusions of donor leukocytes to treat Epstein\u2013Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation. N Engl J Med. 1994;330(17):1185\u201391.","journal-title":"N Engl J Med"},{"issue":"5","key":"2694_CR26","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1038\/nm0596-551","volume":"2","author":"HE Heslop","year":"1996","unstructured":"Heslop HE, Ng C, Li C, Smith CA, Loftin SK, Krance RA, Brenner MK, Rooney CM. Long-term restoration of immunity against Epstein\u2013Barr virus infection by adoptive transfer of gene-modified virus-specific T lymphocytes. Nat Med. 1996;2(5):551\u20135.","journal-title":"Nat Med"},{"issue":"20","key":"2694_CR27","doi-asserted-by":"publisher","first-page":"e173489","DOI":"10.1172\/jci.insight.173489","volume":"9","author":"D Kirchmeier","year":"2024","unstructured":"Kirchmeier D, Deng Y, Rieble L, B\u00f6ni M, L\u00e4derach F, Schuhmachers P, Valencia-Camargo AD, Murer A, Caduff N, Chatterjee B, Chijioke O, Zens K, M\u00fcnz C. Epstein\u2013Barr virus infection induces tissue-resident memory T cells in mucosal lymphoid tissues. JCI Insight. 2024;9(20):e173489.","journal-title":"JCI Insight"},{"issue":"1","key":"2694_CR28","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/s12985-024-02411-0","volume":"21","author":"F Fischer","year":"2024","unstructured":"Fischer F, M\u00fccke J, Werny L, Gerrer K, Mihatsch L, Zehetmaier S, Riedel I, Geisperger J, Bodenhausen M, Schulte-Hillen L, Hoffmann D, Protzer U, Mautner J, Behrends U, Bauer T, K\u00f6rber N. Evaluation of novel Epstein\u2013Barr virus-derived antigen formulations for monitoring virus-specific T cells in pediatric patients with infectious mononucleosis. Virol J. 2024;21(1):139.","journal-title":"Virol J"},{"issue":"10","key":"2694_CR29","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1086\/644644","volume":"200","author":"M Yajima","year":"2009","unstructured":"Yajima M, Imadome K, Nakagawa A, Watanabe S, Terashima K, Nakamura H, Ito M, Shimizu N, Yamamoto N, Fujiwara S. T cell-mediated control of Epstein\u2013Barr virus infection in humanized mice. J Infect Dis. 2009;200(10):1611\u20135.","journal-title":"J Infect Dis"},{"issue":"6","key":"2694_CR30","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1084\/jem.20081720","volume":"206","author":"T Strowig","year":"2009","unstructured":"Strowig T, Gurer C, Ploss A, Liu YF, Arrey F, Sashihara J, Koo G, Rice CM, Young JW, Chadburn A, Cohen JI, M\u00fcnz C. Priming of protective T cell responses against virus-induced tumors in mice with human immune system components. J Exp Med. 2009;206(6):1423\u201334.","journal-title":"J Exp Med"},{"issue":"12","key":"2694_CR31","doi-asserted-by":"publisher","first-page":"2080","DOI":"10.3324\/haematol.2010.029389","volume":"95","author":"J Rohr","year":"2010","unstructured":"Rohr J, Beutel K, Maul-Pavicic A, Vraetz T, Thiel J, Warnatz K, Bondzio I, Gross-Wieltsch U, Sch\u00fcndeln M, Sch\u00fctz B, Woessmann W, Groll AH, Strahm B, Pagel J, Speckmann C, Janka G, Griffiths G, Schwarz K, zur Stadt U, Ehl S. Atypical familial hemophagocytic lymphohistiocytosis due to mutations in UNC13D and STXBP2 overlaps with primary immunodeficiency diseases. Haematologica. 2010;95(12):2080\u20137.","journal-title":"Haematologica"},{"issue":"3","key":"2694_CR32","doi-asserted-by":"publisher","first-page":"449","DOI":"10.3390\/cells12030449","volume":"12","author":"G R\u0119ka","year":"2023","unstructured":"R\u0119ka G, Stefaniak M, Lejman M. Novel molecular therapies and genetic landscape in selected rare diseases with hematologic manifestations: a review of the literature. Cells. 2023;12(3):449.","journal-title":"Cells"},{"issue":"10","key":"2694_CR33","doi-asserted-by":"publisher","first-page":"e1002328","DOI":"10.1371\/journal.ppat.1002328","volume":"7","author":"M Larsen","year":"2011","unstructured":"Larsen M, Sauce D, Deback C, Arnaud L, Mathian A, Miyara M, Boutolleau D, Parizot C, Dorgham K, Papagno L, Appay V, Amoura Z, Gorochov G. Exhausted cytotoxic control of Epstein\u2013Barr virus in human lupus. PLoS Pathog. 2011;7(10):e1002328.","journal-title":"PLoS Pathog"},{"issue":"20","key":"2694_CR34","doi-asserted-by":"publisher","first-page":"e38710","DOI":"10.1016\/j.heliyon.2024.e38710","volume":"10","author":"J Shi","year":"2024","unstructured":"Shi J, Song X, Gao Z, Dai D, Ding F, Wu X, Dai W, Tao G. Programmed death receptor-1\/programmed death-ligand 1 inhibitors: clinical progress and biomarker exploration in gastric cancer. Heliyon. 2024;10(20):e38710.","journal-title":"Heliyon"},{"issue":"7077","key":"2694_CR35","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1038\/nature04444","volume":"439","author":"DL Barber","year":"2006","unstructured":"Barber DL, Wherry E, Masopust D, Zhu B, Allison JP, Sharpe AH, Freeman GJ, Ahmed R. Restoring function in exhausted CD8 T cells during chronic viral infection. Nature. 2006;439(7077):682\u20137.","journal-title":"Nature"},{"issue":"1","key":"2694_CR36","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/ni.1679","volume":"10","author":"SD Blackburn","year":"2009","unstructured":"Blackburn SD, Shin H, Haining WN, Zou T, Workman CJ, Polley A, Betts MR, Freeman GJ, Vignali DA, Wherry EJ. Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection. Nat Immunol. 2009;10(1):29\u201337.","journal-title":"Nat Immunol"},{"issue":"18","key":"2694_CR37","doi-asserted-by":"publisher","first-page":"4749","DOI":"10.1073\/pnas.1718217115","volume":"115","author":"E Ahn","year":"2018","unstructured":"Ahn E, Araki K, Hashimoto M, et al. Role of PD-1 during effector CD8 T cell differentiation. Proc Natl Acad Sci U S A. 2018;115(18):4749\u201354.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"2694_CR38","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1186\/s40425-019-0728-4","volume":"7","author":"S Dorta-Estremera","year":"2019","unstructured":"Dorta-Estremera S, Hegde V, Slay RB, Sun R, Yanamandra AV, Nicholas C, Nookala S, Sierra G, Curran MA, Sastry KJ. Targeting interferon signaling and CTLA-4 enhance the therapeutic efficacy of anti-PD-1 immunotherapy in preclinical model of HPV+ oral cancer. J Immunother Cancer. 2019;7(1):252.","journal-title":"J Immunother Cancer"},{"issue":"11","key":"2694_CR39","doi-asserted-by":"publisher","first-page":"3887","DOI":"10.1002\/j.1460-2075.1992.tb05481.x","volume":"11","author":"Y Ishida","year":"1992","unstructured":"Ishida Y, Agata Y, Shibahara K, Honjo T. Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death. EMBO J. 1992;11(11):3887\u201395.","journal-title":"EMBO J"},{"issue":"5","key":"2694_CR40","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1093\/intimm\/8.5.765","volume":"8","author":"Y Agata","year":"1996","unstructured":"Agata Y, Kawasaki A, Nishimura H, Ishida Y, Tsubata T, Yagita H, Honjo T. Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes. Int Immunol. 1996;8(5):765\u201372.","journal-title":"Int Immunol"},{"issue":"33","key":"2694_CR41","doi-asserted-by":"publisher","first-page":"11823","DOI":"10.1073\/pnas.0505497102","volume":"102","author":"J Wang","year":"2005","unstructured":"Wang J, Yoshida T, Nakaki F, Hiai H, Okazaki T, Honjo T. Establishment of NOD-Pdcd1-\/- mice as an efficient animal model of type I diabetes. Proc Natl Acad Sci U S A. 2005;102(33):11823\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"2694_CR42","doi-asserted-by":"publisher","first-page":"6682","DOI":"10.4049\/jimmunol.0900080","volume":"182","author":"S Chikuma","year":"2009","unstructured":"Chikuma S, Terawaki S, Hayashi T, Nabeshima R, Yoshida T, Shibayama S, Okazaki T, Honjo T. PD-1-mediated suppression of IL-2 production induces CD8+ T cell anergy in vivo. J Immunol. 2009;182(11):6682\u20139.","journal-title":"J Immunol"},{"key":"2694_CR43","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1111\/j.1749-6632.2010.05919.x","volume":"1217","author":"BT Fife","year":"2011","unstructured":"Fife BT, Pauken K. The role of the PD-1 pathway in autoimmunity and peripheral tolerance. Ann N Y Acad Sci. 2011;1217:45\u201359.","journal-title":"Ann N Y Acad Sci"},{"issue":"5","key":"2694_CR44","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1016\/j.immuni.2016.04.020","volume":"44","author":"JH Esensten","year":"2016","unstructured":"Esensten JH, Helou Y, Chopra G, Weiss A, Bluestone JA. CD28 costimulation: from mechanism to therapy. Immunity. 2016;44(5):973\u201388.","journal-title":"Immunity"},{"issue":"2","key":"2694_CR45","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1086\/302761","volume":"66","author":"CL Bennett","year":"2000","unstructured":"Bennett CL, Yoshioka R, Kiyosawa H, Barker DF, Fain PR, Shigeoka AO, Chance PF. X-Linked syndrome of polyendocrinopathy, immune dysfunction, and diarrhea maps to Xp11.23-Xq13.3. Am J Hum Genet. 2000;66(2):461\u20138.","journal-title":"Am J Hum Genet"},{"issue":"2","key":"2694_CR46","doi-asserted-by":"publisher","first-page":"711","DOI":"10.4049\/jimmunol.170.2.711","volume":"170","author":"F Bennett","year":"2003","unstructured":"Bennett F, Luxenberg D, Ling V, Wang IM, Marquette K, Lowe D, Khan N, Veldman G, Jacobs KA, Valge-Archer VE, Collins M, Carreno BM. Program death-1 engagement upon TCR activation has distinct effects on costimulation and cytokine-driven proliferation: attenuation of ICOS, IL-4, and IL-21, but not CD28, IL-7, and IL-15 responses. J Immunol. 2003;170(2):711\u20138.","journal-title":"J Immunol"},{"issue":"3","key":"2694_CR47","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/nri.2017.108","volume":"18","author":"AH Sharpe","year":"2018","unstructured":"Sharpe AH, Pauken K. The diverse functions of the PD1 inhibitory pathway. Nat Rev Immunol. 2018;18(3):153\u201367.","journal-title":"Nat Rev Immunol"},{"issue":"8","key":"2694_CR48","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/nri3862","volume":"15","author":"EJ Wherry","year":"2015","unstructured":"Wherry EJ, Kurachi M. Molecular and cellular insights into T cell exhaustion. Nat Rev Immunol. 2015;15(8):486\u201399.","journal-title":"Nat Rev Immunol"},{"issue":"7","key":"2694_CR49","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1084\/jem.20142237","volume":"212","author":"PM Odorizzi","year":"2015","unstructured":"Odorizzi PM, Pauken K, Paley MA, Sharpe A, Wherry EJ. Genetic absence of PD-1 promotes accumulation of terminally differentiated exhausted CD8+ T cells. J Exp Med. 2015;212(7):1125\u201337.","journal-title":"J Exp Med"},{"key":"2694_CR50","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/978-3-319-15774-0_10","volume":"850","author":"D Zehn","year":"2015","unstructured":"Zehn D, Wherry E. Immune memory and exhaustion: clinically relevant lessons from the LCMV model. Adv Exp Med Biol. 2015;850:137\u201352.","journal-title":"Adv Exp Med Biol"},{"issue":"6","key":"2694_CR51","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1172\/JCI26856","volume":"116","author":"DG Brooks","year":"2006","unstructured":"Brooks DG, McGavern D, Oldstone MB. Reprogramming of antiviral T cells prevents inactivation and restores T cell activity during persistent viral infection. J Clin Invest. 2006;116(6):1675\u201385.","journal-title":"J Clin Invest"},{"issue":"33","key":"2694_CR52","doi-asserted-by":"publisher","first-page":"14733","DOI":"10.1073\/pnas.1009731107","volume":"107","author":"HT Jin","year":"2010","unstructured":"Jin HT, Anderson A, Tan WG, West EE, Ha SJ, Araki K, Freeman GJ, Kuchroo VK, Ahmed R. Cooperation of Tim-3 and PD-1 in CD8 T-cell exhaustion during chronic viral infection. Proc Natl Acad Sci U S A. 2010;107(33):14733\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2694_CR53","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1146\/annurev.immunol.26.021607.090331","volume":"26","author":"ME Keir","year":"2008","unstructured":"Keir ME, Butte M, Freeman GJ, Sharpe AH. PD-1 and its ligands in tolerance and immunity. Annu Rev Immunol. 2008;26:677\u2013704.","journal-title":"Annu Rev Immunol"},{"issue":"8","key":"2694_CR54","doi-asserted-by":"publisher","first-page":"3011","DOI":"10.1073\/pnas.0712278105","volume":"105","author":"DY Lin","year":"2008","unstructured":"Lin DY, Tanaka Y, Iwasaki M, Gittis AG, Su HP, Mikami B, Okazaki T, Honjo T, Minato N, Garboczi DN. The PD-1\/PD-L1 complex resembles the antigen-binding Fv domains of antibodies and T cell receptors. Proc Natl Acad Sci U S A. 2008;105(8):3011\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"13","key":"2694_CR55","doi-asserted-by":"publisher","first-page":"2062","DOI":"10.1182\/blood-2013-10-535443","volume":"123","author":"DD Twa","year":"2014","unstructured":"Twa DD, Chun Chan F, Ben-Neriah S, Woolcock BW, Mottok A, Tan KL, Slack GW, Gunawardana J, Lim RS, McPherson AW, Kridel R, Telenius A, Scott DW, Savage KJ, Shah SP, Gascoyne RD, Steidl C. Genomic rearrangements involving programmed death ligands are recurrent in primary mediastinal large B-cell lymphoma. Blood. 2014;123(13):2062\u20135.","journal-title":"Blood"},{"issue":"6","key":"2694_CR56","doi-asserted-by":"publisher","first-page":"3729","DOI":"10.1128\/MCB.14.6.3729","volume":"14","author":"LK Gauen","year":"1994","unstructured":"Gauen LK, Zhu Y, Letourneur F, Hu Q, Bolen JB, Matis LA, Klausner RD, Shaw AS. Interactions of p59fyn and ZAP-70 with T-cell receptor activation motifs: defining the nature of a signalling motif. Mol Cell Biol. 1994;14(6):3729\u201341.","journal-title":"Mol Cell Biol"},{"issue":"4","key":"2694_CR57","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/0092-8674(92)90428-F","volume":"70","author":"DB Straus","year":"1992","unstructured":"Straus DB, Weiss A. Genetic evidence for the involvement of the lck tyrosine kinase in signal transduction through the T cell antigen receptor. Cell. 1992;70(4):585\u201393.","journal-title":"Cell"},{"issue":"12","key":"2694_CR58","doi-asserted-by":"publisher","first-page":"2341","DOI":"10.1016\/j.str.2015.09.010","volume":"23","author":"KM Zak","year":"2015","unstructured":"Zak KM, Kitel R, Przetocka S, Golik P, Guzik K, Musielak B, D\u00f6mling A, Dubin G, Holak TA. Structure of the complex of human programmed death 1, PD-1, and its ligand PD-L1. Structure. 2015;23(12):2341\u20138.","journal-title":"Structure"},{"issue":"2","key":"2694_CR59","doi-asserted-by":"publisher","first-page":"945","DOI":"10.4049\/jimmunol.173.2.945","volume":"173","author":"JM Chemnitz","year":"2004","unstructured":"Chemnitz JM, Parry R, Nichols KE, June CH, Riley JL. SHP-1 and SHP-2 associate with immunoreceptor tyrosine-based switch motif of programmed death 1 upon primary human T cell stimulation, but only receptor ligation prevents T cell activation. J Immunol. 2004;173(2):945\u201354.","journal-title":"J Immunol"},{"key":"2694_CR60","doi-asserted-by":"publisher","first-page":"1296341","DOI":"10.3389\/fimmu.2023.1296341","volume":"14","author":"A Parvez","year":"2023","unstructured":"Parvez A, Choudhary F, Mudgal P, Khan R, Qureshi KA, Farooqi H, Aspatwar A. PD-1 and PD-L1: architects of immune symphony and immunotherapy breakthroughs in cancer treatment. Front Immunol. 2023;14:1296341.","journal-title":"Front Immunol"},{"key":"2694_CR61","doi-asserted-by":"publisher","first-page":"339","DOI":"10.3389\/fimmu.2020.00339","volume":"11","author":"Y Jiang","year":"2020","unstructured":"Jiang Y, Zhao X, Fu J, Wang H. Progress and challenges in precise treatment of tumors with PD-1\/PD-L1 blockade. Front Immunol. 2020;11:339.","journal-title":"Front Immunol"},{"issue":"19","key":"2694_CR62","doi-asserted-by":"publisher","first-page":"3167","DOI":"10.1200\/JCO.2009.26.7609","volume":"28","author":"JR Brahmer","year":"2010","unstructured":"Brahmer JR, Drake C, Wollner I, Powderly JD, Picus J, Sharfman WH, Stankevich E, Pons A, Salay TM, McMiller TL, Gilson MM, Wang C, Selby M, Taube JM, Anders R, Chen L, Korman AJ, Pardoll DM, Lowy I, Topalian SL. Phase I study of single-agent anti-programmed death-1 (MDX-1106) in refractory solid tumors: safety, clinical activity, pharmacodynamics, and immunologic correlates. J Clin Oncol. 2010;28(19):3167\u201375.","journal-title":"J Clin Oncol"},{"issue":"7","key":"2694_CR63","doi-asserted-by":"publisher","first-page":"3635","DOI":"10.1182\/blood-2007-11-123141","volume":"111","author":"T Azuma","year":"2008","unstructured":"Azuma T, Yao S, Zhu G, Flies AS, Flies SJ, Chen L. B7\u2013H1 is a ubiquitous antiapoptotic receptor on cancer cells. Blood. 2008;111(7):3635\u201343.","journal-title":"Blood"},{"issue":"1","key":"2694_CR64","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1056\/NEJMoa1504030","volume":"373","author":"J Larkin","year":"2015","unstructured":"Larkin J, Wolchok JD. Combined nivolumab and ipilimumab or monotherapy in untreated melanoma. N Engl J Med. 2015;373(1):23\u201334.","journal-title":"N Engl J Med"},{"issue":"10030","key":"2694_CR65","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1016\/S0140-6736(16)00587-0","volume":"387","author":"L Fehrenbacher","year":"2016","unstructured":"Fehrenbacher L, Spira A, Ballinger M, Kowanetz M, Vansteenkiste J, Mazieres J, Park K, Smith D, Artal-Cortes A, Lewanski C, Braiteh F, Waterkamp D, He P, Zou W, Chen DS, Yi J, Sandler A, Rittmeyer A, POPLAR Study Group. Atezolizumab versus docetaxel for patients with previously treated non-small-cell lung cancer (POPLAR): a multicentre, open-label, phase 2 randomised controlled trial. Lancet. 2016;387(10030):1837\u201346.","journal-title":"Lancet"},{"key":"2694_CR66","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1056\/NEJMoa1507643","volume":"373","author":"L Paz-Ares","year":"2015","unstructured":"Paz-Ares L, Horn L, Spigel DR, Steins M, Ready NE, Chow LQ, Vokes EE, Felip E, Holgado E, et al. Nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer. N Engl J Med. 2015;373:1627\u201339.","journal-title":"N Engl J Med"},{"issue":"11","key":"2694_CR67","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1016\/S1470-2045(17)30616-2","volume":"18","author":"AV Balar","year":"2017","unstructured":"Balar AV, Castellano D, O\u2019Donnell PH, Grivas P, Vuky J, Powles T, Plimack ER, Hahn NM, de Wit R, Pang L, Savage MJ, Perini RF, Keefe SM, Bajorin D, Bellmunt J. First-line pembrolizumab in cisplatin-ineligible patients with locally advanced and unresectable or metastatic urothelial cancer (KEYNOTE-052): a multicentre, single-arm, phase 2 study. Lancet Oncol. 2017;18(11):1483\u201392.","journal-title":"Lancet Oncol"},{"issue":"10","key":"2694_CR68","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1016\/S1470-2045(16)30364-3","volume":"17","author":"HL Kaufman","year":"2016","unstructured":"Kaufman HL, Russell J, Hamid O, Bhatia S, Terheyden P, D\u2019Angelo SP, Shih KC, Lebb\u00e9 C, Linette GP, Milella M, Brownell I, Lewis KD, Lorch JH, Chin K, Mahnke L, von Heydebreck A, Cuillerot JM, Nghiem P. Avelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: a multicentre, single-group, open-label, phase 2 trial. Lancet Oncol. 2016;17(10):1374\u201385.","journal-title":"Lancet Oncol"},{"issue":"Pt 6","key":"2694_CR69","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1099\/vir.0.81920-0","volume":"87","author":"A Bertoletti","year":"2006","unstructured":"Bertoletti A, Gehring A. The immune response during hepatitis B virus infection. J Gen Virol. 2006;87(Pt 6):1439\u201349.","journal-title":"J Gen Virol"},{"issue":"10","key":"2694_CR70","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1038\/nm1482","volume":"12","author":"L Trautmann","year":"2006","unstructured":"Trautmann L, Janbazian L, Chomont N, Said EA, Gimmig S, Bessette B, Boulassel MR, Delwart E, Sepulveda H, Balderas RS, Routy JP, Haddad EK, Sekaly RP. Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction. Nat Med. 2006;12(10):1198\u2013202.","journal-title":"Nat Med"},{"issue":"41","key":"2694_CR71","doi-asserted-by":"publisher","first-page":"5129","DOI":"10.3748\/wjg.15.5129","volume":"15","author":"JR Larrubia","year":"2009","unstructured":"Larrubia JR, Benito-Mart\u00ednez S, Miquel J, Calvino M, Sanz-de-Villalobos E, Parra-Cid T. Costimulatory molecule programmed death-1 in the cytotoxic response during chronic hepatitis C. World J Gastroenterol. 2009;15(41):5129\u201340.","journal-title":"World J Gastroenterol"},{"issue":"4","key":"2694_CR72","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/j.immuni.2007.09.006","volume":"27","author":"EJ Wherry","year":"2007","unstructured":"Wherry EJ, Ha S, Kaech SM, Haining WN, Sarkar S, Kalia V, Subramaniam S, Blattman JN, Barber DL, Ahmed R. Molecular signature of CD8+ T cell exhaustion during chronic viral infection. Immunity. 2007;27(4):670\u201384.","journal-title":"Immunity"},{"issue":"2","key":"2694_CR73","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.immuni.2014.01.005","volume":"40","author":"A Crawford","year":"2014","unstructured":"Crawford A, Angelosanto J, Kao C, Doering TA, Odorizzi PM, Barnett BE, Wherry EJ. Molecular and transcriptional basis of CD4\u207a T cell dysfunction during chronic infection. Immunity. 2014;40(2):289\u2013302.","journal-title":"Immunity"},{"issue":"8","key":"2694_CR74","doi-asserted-by":"publisher","first-page":"4215","DOI":"10.1128\/JVI.02844-06","volume":"81","author":"C Boni","year":"2007","unstructured":"Boni C, Fisicaro P, Valdatta C, Amadei B, Di Vincenzo P, Giuberti T, Laccabue D, Zerbini A, Cavalli A, Missale G, Bertoletti A, Ferrari C. Characterization of hepatitis B virus (HBV)-specific T-cell dysfunction in chronic HBV infection. J Virol. 2007;81(8):4215\u201325.","journal-title":"J Virol"},{"issue":"4","key":"2694_CR75","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1016\/j.molimm.2007.07.038","volume":"45","author":"G Peng","year":"2008","unstructured":"Peng G, Li S, Wu W, Tan X, Chen Y, Chen Z. PD-1 upregulation is associated with HBV-specific T cell dysfunction in chronic hepatitis B patients. Mol Immunol. 2008;45(4):963\u201370.","journal-title":"Mol Immunol"},{"issue":"28","key":"2694_CR76","doi-asserted-by":"publisher","first-page":"4551","DOI":"10.3748\/wjg.14.4551","volume":"14","author":"P Ye","year":"2008","unstructured":"Ye P, Weng Z, Zhang SL, Zhang JA, Zhao L, Dong JH, Jie SH, Pang R, Wei RH. Programmed death-1 expression is associated with the disease status in hepatitis B virus infection. World J Gastroenterol. 2008;14(28):4551\u20137.","journal-title":"World J Gastroenterol"},{"issue":"1","key":"2694_CR77","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s12865-019-0309-9","volume":"20","author":"Y Dong","year":"2019","unstructured":"Dong Y, Li X, Zhang L, Zhu Q, Chen C, Bao J, Chen Y. CD4+ T cell exhaustion revealed by high PD-1 and LAG-3 expression and the loss of helper T cell function in chronic hepatitis B. BMC Immunol. 2019;20(1):27.","journal-title":"BMC Immunol"},{"issue":"6347","key":"2694_CR78","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1126\/science.aal1962","volume":"357","author":"E Billerbeck","year":"2017","unstructured":"Billerbeck E, Wolfisberg R, Fahn\u00f8e U, Xiao JW, Quirk C, Luna JM, Cullen JM, Hartlage AS, Chiriboga L, Ghoshal K, Lipkin WI, Bukh J, Scheel TKH, Kapoor A, Rice CM. Mouse models of acute and chronic hepacivirus infection. Science. 2017;357(6347):204\u20138.","journal-title":"Science"},{"issue":"8","key":"2694_CR79","doi-asserted-by":"publisher","first-page":"2967","DOI":"10.1172\/JCI62860","volume":"122","author":"JJ Erickson","year":"2012","unstructured":"Erickson JJ, Gilchuk P, Hastings AK, Tollefson SJ, Johnson M, Downing MB, Boyd KL, Johnson JE, Kim AS, Joyce S, Williams JV. Viral acute lower respiratory infections impair CD8+ T cells through PD-1. J Clin Invest. 2012;122(8):2967\u201382.","journal-title":"J Clin Invest"},{"issue":"11","key":"2694_CR80","doi-asserted-by":"publisher","first-page":"6280","DOI":"10.4049\/jimmunol.1003870","volume":"186","author":"SR Allie","year":"2011","unstructured":"Allie SR, Zhang W, Fuse S, Usherwood EJ. Programmed death 1 regulates development of central memory CD8 T cells after acute viral infection. J Immunol. 2011;186(11):6280\u20136.","journal-title":"J Immunol"},{"issue":"8","key":"2694_CR81","doi-asserted-by":"publisher","first-page":"2592","DOI":"10.4049\/jimmunol.1701231","volume":"200","author":"PT Sage","year":"2018","unstructured":"Sage PT, Schildberg F, Sobel RA, Kuchroo VK, Freeman GJ, Sharpe AH. Dendritic cell PD-L1 limits autoimmunity and follicular T cell differentiation and function. J Immunol. 2018;200(8):2592\u2013602.","journal-title":"J Immunol"},{"issue":"3","key":"2694_CR82","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/ni1443","volume":"8","author":"AH Sharpe","year":"2007","unstructured":"Sharpe AH, Wherry E, Ahmed R, Freeman GJ. The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection. Nat Immunol. 2007;8(3):239\u201345.","journal-title":"Nat Immunol"},{"issue":"7","key":"2694_CR83","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1053\/j.gastro.2008.03.037","volume":"134","author":"Z Zhang","year":"2008","unstructured":"Zhang Z, Zhang J, Wherry EJ, Jin B, Xu B, Zou ZS, Zhang SY, Li BS, Wang HF, Wu H, Lau GK, Fu YX, Wang FS. Dynamic programmed death 1 expression by virus-specific CD8 T cells correlates with the outcome of acute hepatitis B. Gastroenterology. 2008;134(7):1938\u201349.","journal-title":"Gastroenterology"},{"issue":"2","key":"2694_CR84","doi-asserted-by":"publisher","first-page":"288","DOI":"10.5009\/gnl14368","volume":"10","author":"H Cho","year":"2016","unstructured":"Cho H, Kang H, Kim CW, Kim HY, Jang JW, Yoon SK, Lee CD. Phenotypic characteristics of PD-1 and CTLA-4 expression in symptomatic acute hepatitis A. Gut Liver. 2016;10(2):288\u201394.","journal-title":"Gut Liver"},{"issue":"12","key":"2694_CR85","doi-asserted-by":"publisher","first-page":"8215","DOI":"10.4049\/jimmunol.181.12.8215","volume":"181","author":"A Rutebemberwa","year":"2008","unstructured":"Rutebemberwa A, Ray S, Astemborski J, Levine J, Liu L, Dowd KA, Clute S, Wang C, Korman A, Sette A, Sidney J, Pardoll DM, Cox AL. High-programmed death-1 levels on hepatitis C virus-specific T cells during acute infection are associated with viral persistence and require preservation of cognate antigen during chronic infection. J Immunol. 2008;181(12):8215\u201325.","journal-title":"J Immunol"},{"issue":"3","key":"2694_CR86","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.coi.2010.03.007","volume":"22","author":"KE Brown","year":"2010","unstructured":"Brown KE, Freeman G, Wherry EJ, Sharpe AH. Role of PD-1 in regulating acute infections. Curr Opin Immunol. 2010;22(3):397\u2013401.","journal-title":"Curr Opin Immunol"},{"issue":"13","key":"2694_CR87","doi-asserted-by":"publisher","first-page":"2485","DOI":"10.1084\/jem.20121015","volume":"209","author":"H Frebel","year":"2012","unstructured":"Frebel H, Nindl V, Schuepbach RA, Braunschweiler T, Richter K, Vogel J, Wagner CA, Loffing-Cueni D, Kurrer M, Ludewig B, Oxenius A. Programmed death 1 protects from fatal circulatory failure during systemic virus infection of mice. J Exp Med. 2012;209(13):2485\u201399.","journal-title":"J Exp Med"},{"key":"2694_CR88","doi-asserted-by":"publisher","first-page":"207","DOI":"10.3389\/fcimb.2019.00207","volume":"9","author":"G Sch\u00f6nrich","year":"2019","unstructured":"Sch\u00f6nrich G, Raftery M. The PD-1\/PD-L1 axis and virus infections: a delicate balance. Front Cell Infect Microbiol. 2019;9:207.","journal-title":"Front Cell Infect Microbiol"},{"issue":"6129","key":"2694_CR89","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1126\/science.1235214","volume":"340","author":"JR Teijaro","year":"2013","unstructured":"Teijaro JR, Ng C, Lee AM, Sullivan BM, Sheehan KC, Welch M, Schreiber RD, de la Torre JC, Oldstone MB. Persistent LCMV infection is controlled by blockade of type I interferon signaling. Science. 2013;340(6129):207\u201311.","journal-title":"Science"},{"issue":"6129","key":"2694_CR90","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1126\/science.1235208","volume":"340","author":"EB Wilson","year":"2013","unstructured":"Wilson EB, Yamada D, Elsaesser H, Herskovitz J, Deng J, Cheng G, Aronow BJ, Karp CL, Brooks DG. Blockade of chronic type I interferon signaling to control persistent LCMV infection. Science. 2013;340(6129):202\u20137.","journal-title":"Science"},{"issue":"15","key":"2694_CR91","doi-asserted-by":"publisher","first-page":"4719","DOI":"10.1073\/pnas.1502619112","volume":"112","author":"AK McElroy","year":"2015","unstructured":"McElroy AK, Akondy R, Davis CW, Ellebedy AH, Mehta AK, Kraft CS, Lyon GM, Ribner BS, Varkey J, Sidney J, Sette A, Campbell S, Str\u00f6her U, Damon I, Nichol ST, Spiropoulou CF, Ahmed R. Human Ebola virus infection results in substantial immune activation. Proc Natl Acad Sci U S A. 2015;112(15):4719\u201324.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2694_CR92","doi-asserted-by":"publisher","first-page":"2560","DOI":"10.3389\/fimmu.2018.02560","volume":"9","author":"MJ Raftery","year":"2018","unstructured":"Raftery MJ, Abdelaziz M, Hofmann J, Sch\u00f6nrich G. Hantavirus-driven PD-L1\/PD-L2 upregulation: an imperfect viral immune evasion mechanism. Front Immunol. 2018;9:2560.","journal-title":"Front Immunol"},{"issue":"12","key":"2694_CR93","doi-asserted-by":"publisher","first-page":"6672","DOI":"10.1128\/JVI.00825-14","volume":"88","author":"R Plan\u00e8s","year":"2014","unstructured":"Plan\u00e8s R, BenMohamed L, Leghmari K, Delobel P, Izopet J, Bahraoui E. HIV-1 Tat protein induces PD-L1 (B7\u2013H1) expression on dendritic cells through tumor necrosis factor alpha- and toll-like receptor 4-mediated mechanisms. J Virol. 2014;88(12):6672\u201389.","journal-title":"J Virol"},{"issue":"1","key":"2694_CR94","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1053\/j.gastro.2009.09.009","volume":"138","author":"Z Tu","year":"2010","unstructured":"Tu Z, Pierce R, Kurtis J, Kuroki Y, Crispe IN, Orloff MS. Hepatitis C virus core protein subverts the antiviral activities of human Kupffer cells. Gastroenterology. 2010;138(1):305\u201314.","journal-title":"Gastroenterology"},{"issue":"1","key":"2694_CR95","doi-asserted-by":"publisher","first-page":"e0170516","DOI":"10.1371\/journal.pone.0170516","volume":"12","author":"N Zhai","year":"2017","unstructured":"Zhai N, Li H, Song H, Yang Y, Cui A, Li T, Niu J, Crispe IN, Su L, Tu Z. Hepatitis C virus induces MDSCs-like monocytes through TLR2\/PI3K\/AKT\/STAT3 signaling. PLoS ONE. 2017;12(1):e0170516.","journal-title":"PLoS ONE"},{"issue":"12","key":"2694_CR96","doi-asserted-by":"publisher","first-page":"e0205886","DOI":"10.1371\/journal.pone.0205886","volume":"13","author":"M Kakizaki","year":"2018","unstructured":"Kakizaki M, Yamamoto Y, Yabuta S, Kurosaki N, Kagawa T, Kotani A. The immunological function of extracellular vesicles in hepatitis B virus-infected hepatocytes. PLoS ONE. 2018;13(12):e0205886.","journal-title":"PLoS ONE"},{"issue":"3","key":"2694_CR97","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.immuni.2018.03.014","volume":"48","author":"C Sun","year":"2018","unstructured":"Sun C, Mezzadra R, Schumacher TN. Regulation and function of the PD-L1 checkpoint. Immunity. 2018;48(3):434\u201352.","journal-title":"Immunity"},{"key":"2694_CR98","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1146\/annurev-immunol-032414-112326","volume":"33","author":"GS Taylor","year":"2015","unstructured":"Taylor GS, Long H, Brooks JM, Rickinson AB, Hislop AD. The immunology of Epstein\u2013Barr virus-induced disease. Annu Rev Immunol. 2015;33:787\u2013821.","journal-title":"Annu Rev Immunol"},{"key":"2694_CR99","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1146\/annurev.immunol.25.022106.141553","volume":"25","author":"AD Hislop","year":"2007","unstructured":"Hislop AD, Taylor G, Sauce D, Rickinson AB. Cellular responses to viral infection in humans: lessons from Epstein\u2013Barr virus. Annu Rev Immunol. 2007;25:587\u2013617.","journal-title":"Annu Rev Immunol"},{"key":"2694_CR100","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1146\/annurev.pathol.1.110304.100209","volume":"1","author":"JL Kutok","year":"2006","unstructured":"Kutok JL, Wang F. Spectrum of Epstein\u2013Barr virus-associated diseases. Annu Rev Pathol. 2006;1:375\u2013404.","journal-title":"Annu Rev Pathol"},{"issue":"6","key":"2694_CR101","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1086\/428097","volume":"191","author":"S Fafi-Kremer","year":"2005","unstructured":"Fafi-Kremer S, Morand P, Brion JP, Pavese P, Baccard M, Germi R, Genoulaz O, Nicod S, Jolivet M, Ruigrok RW, Stahl JP, Seigneurin JM. Long-term shedding of infectious Epstein\u2013Barr virus after infectious mononucleosis. J Infect Dis. 2005;191(6):985\u20139.","journal-title":"J Infect Dis"},{"issue":"6716","key":"2694_CR102","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/16717","volume":"397","author":"A Hutloff","year":"1999","unstructured":"Hutloff A, Dittrich A, Beier KC, Eljaschewitsch B, Kraft R, Anagnostopoulos I, Kroczek RA. ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28. Nature. 1999;397(6716):263\u20136.","journal-title":"Nature"},{"issue":"4","key":"2694_CR103","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1084\/jem.20130590","volume":"211","author":"X Fan","year":"2014","unstructured":"Fan X, Quezada S, Sepulveda MA, Sharma P, Allison JP. Engagement of the ICOS pathway markedly enhances efficacy of CTLA-4 blockade in cancer immunotherapy. J Exp Med. 2014;211(4):715\u201325.","journal-title":"J Exp Med"},{"issue":"4","key":"2694_CR104","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1016\/S0891-5520(20)30708-X","volume":"9","author":"N Basgoz","year":"1995","unstructured":"Basgoz N, Preiksaitis J. Post-transplant lymphoproliferative disorder. Infect Dis Clin North Am. 1995;9(4):901\u201323.","journal-title":"Infect Dis Clin North Am"},{"issue":"10","key":"2694_CR105","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1016\/S0959-8049(01)00123-X","volume":"37","author":"RF Ambinder","year":"2001","unstructured":"Ambinder RF. Epstein\u2013Barr virus associated lymphoproliferations in the AIDS setting. Eur J Cancer. 2001;37(10):1209\u201316.","journal-title":"Eur J Cancer"},{"issue":"1","key":"2694_CR106","doi-asserted-by":"publisher","first-page":"181","DOI":"10.4049\/jimmunol.1102277","volume":"189","author":"S Durand-Panteix","year":"2012","unstructured":"Durand-Panteix S, Farhat M, Youlyouz-Marfak I, Rouaud P, Ouk-Martin C, David A, Faumont N, Feuillard J, Jayat-Vignoles C. B7\u2013H1, which represses EBV-immortalized B cell killing by autologous T and NK cells, is oppositely regulated by c-Myc and EBV latency III program at both mRNA and secretory lysosome levels. J Immunol. 2012;189(1):181\u201390.","journal-title":"J Immunol"},{"issue":"4","key":"2694_CR107","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/nrclinonc.2016.168","volume":"14","author":"A Goodman","year":"2017","unstructured":"Goodman A, Patel S, Kurzrock R. PD-1-PD-L1 immune-checkpoint blockade in B-cell lymphomas. Nat Rev Clin Oncol. 2017;14(4):203\u201320.","journal-title":"Nat Rev Clin Oncol"},{"issue":"4","key":"2694_CR108","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.immuni.2015.04.005","volume":"42","author":"EC Rosser","year":"2015","unstructured":"Rosser EC, Mauri C. Regulatory B cells: origin, phenotype, and function. Immunity. 2015;42(4):607\u201312.","journal-title":"Immunity"},{"issue":"4 Suppl 98","key":"2694_CR109","first-page":"1","volume":"34","author":"S Fillatreau","year":"2016","unstructured":"Fillatreau S. Regulatory roles of B cells in infectious diseases. Clin Exp Rheumatol. 2016;34(4 Suppl 98):1\u20135.","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"2694_CR110","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.immuni.2009.11.009","volume":"32","author":"PA Blair","year":"2010","unstructured":"Blair PA, Nore\u00f1a L, Flores-Borja F, Rawlings DJ, Isenberg DA, Ehrenstein MR, Mauri C. CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic Lupus Erythematosus patients. Immunity. 2010;32(1):129\u201340.","journal-title":"Immunity"},{"issue":"6","key":"2694_CR111","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.4049\/jimmunol.1801420","volume":"203","author":"H Auclair","year":"2019","unstructured":"Auclair H, Ouk-Martin C, Roland L, Santa P, Al Mohamad H, Faumont N, Feuillard J, Jayat-Vignoles C. EBV latency III-transformed B cells are inducers of conventional and unconventional regulatory T cells in a PD-L1-dependent manner. J Immunol. 2019;203(6):1665\u201374.","journal-title":"J Immunol"},{"issue":"19","key":"2694_CR112","doi-asserted-by":"publisher","first-page":"31347","DOI":"10.18632\/oncotarget.15532","volume":"8","author":"M Zhang","year":"2017","unstructured":"Zhang M, Sun H, Zhao S, Wang Y, Pu H, Wang Y, Zhang Q. Expression of PD-L1 and prognosis in breast cancer: a meta-analysis. Oncotarget. 2017;8(19):31347\u201354.","journal-title":"Oncotarget"},{"issue":"111","key":"2694_CR113","doi-asserted-by":"publisher","first-page":"111ra120","DOI":"10.1126\/scitranslmed.3003130","volume":"3","author":"S Amarnath","year":"2011","unstructured":"Amarnath S, Mangus C, Wang JC, Wei F, He A, Kapoor V, Foley JE, Massey PR, Felizardo TC, Riley JL, Levine BL, June CH, Medin JA, Fowler DH. The PDL1-PD1 axis converts human TH1 cells into regulatory T cells. Sci Transl Med. 2011;3(111):111ra120.","journal-title":"Sci Transl Med"},{"issue":"6","key":"2694_CR114","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1309\/AJCPUJGMVV6ZF4GG","volume":"144","author":"C Chang","year":"2015","unstructured":"Chang C, Wu S, Kang YW, Lin KP, Chen TY, Medeiros LJ, Chang KC. High levels of regulatory T cells in blood are a poor prognostic factor in patients with diffuse large B-cell lymphoma. Am J Clin Pathol. 2015;144(6):935\u201344.","journal-title":"Am J Clin Pathol"},{"key":"2694_CR115","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2020.105127","volume":"113","author":"D Johnson","year":"2021","unstructured":"Johnson D, Ma B. Targeting the PD-1\/ PD-L1 interaction in nasopharyngeal carcinoma. Oral Oncol. 2021;113: 105127.","journal-title":"Oral Oncol"},{"issue":"5","key":"2694_CR116","doi-asserted-by":"publisher","first-page":"417","DOI":"10.2217\/fon-2017-0436","volume":"14","author":"SS Joshi","year":"2018","unstructured":"Joshi SS, Maron S, Catenacci DV. Pembrolizumab for treatment of advanced gastric and gastroesophageal junction adenocarcinoma. Future Oncol. 2018;14(5):417\u201330.","journal-title":"Future Oncol"},{"issue":"3","key":"2694_CR117","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/s00428-020-02901-w","volume":"478","author":"T Takahara","year":"2021","unstructured":"Takahara T, Satou A, Ishikawa E, Kohno K, Kato S, Suzuki Y, Takahashi E, Ohashi A, Asano N, Tsuzuki T, Nakamura S. Clinicopathological analysis of neoplastic PD-L1-positive EBV+ diffuse large B cell lymphoma, not otherwise specified, in a Japanese cohort. Virchows Arch. 2021;478(3):541\u201352.","journal-title":"Virchows Arch"},{"issue":"23","key":"2694_CR118","doi-asserted-by":"publisher","first-page":"12189","DOI":"10.18632\/oncotarget.2608","volume":"5","author":"W Fang","year":"2014","unstructured":"Fang W, Zhang J, Hong S, Zhan J, Chen N, Qin T, Tang Y, Zhang Y, Kang S, Zhou T, Wu X, Liang W, Hu Z, Ma Y, Zhao Y, Tian Y, Yang Y, Xue C, Yan Y, Hou X, Huang P, Huang Y, Zhao H, Zhang L. EBV-driven LMP1 and IFN-\u03b3 up-regulate PD-L1 in nasopharyngeal carcinoma: implications for oncotargeted therapy. Oncotarget. 2014;5(23):12189\u2013202.","journal-title":"Oncotarget"},{"issue":"6","key":"2694_CR119","doi-asserted-by":"publisher","first-page":"3154","DOI":"10.1128\/JVI.02474-07","volume":"82","author":"V Kasprowicz","year":"2008","unstructured":"Kasprowicz V, Schulze zur Wiesch J, Kuntzen T, Nolan BE, Longworth S, Berical A, Blum J, McMahon C, Reyor LL, Elias N, Kwok WW, McGovern BG, Freeman G, Chung RT, Klenerman P, Lewis-Ximenez L, Walker BD, Allen TM, Kim AY, Lauer GM. High level of PD-1 expression on hepatitis C virus (HCV)-specific CD8+ and CD4+ T cells during acute HCV infection, irrespective of clinical outcome. J Virol. 2008;82(6):3154\u201360.","journal-title":"J Virol"},{"issue":"1","key":"2694_CR120","doi-asserted-by":"publisher","first-page":"476","DOI":"10.4049\/jimmunol.0902781","volume":"184","author":"NC Salisch","year":"2010","unstructured":"Salisch NC, Kaufmann D, Awad AS, Reeves RK, Tighe DP, Li Y, Piatak M Jr, Lifson JD, Evans DT, Pereyra F, Freeman GJ, Johnson RP. Inhibitory TCR coreceptor PD-1 is a sensitive indicator of low-level replication of SIV and HIV-1. J Immunol. 2010;184(1):476\u201387.","journal-title":"J Immunol"},{"issue":"39","key":"2694_CR121","doi-asserted-by":"publisher","first-page":"15016","DOI":"10.1073\/pnas.0801497105","volume":"105","author":"SD Blackburn","year":"2008","unstructured":"Blackburn SD, Shin H, Freeman GJ, Wherry EJ. Selective expansion of a subset of exhausted CD8 T cells by alphaPD-L1 blockade. Proc Natl Acad Sci U S A. 2008;105(39):15016\u201321.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"2694_CR122","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1002\/(SICI)1096-9896(199706)182:2<151::AID-PATH824>3.0.CO;2-3","volume":"182","author":"G Niedobitek","year":"1997","unstructured":"Niedobitek G, Agathanggelou A, Herbst H, Whitehead L, Wright DH, Young LS. Epstein\u2013Barr virus (EBV) infection in infectious mononucleosis: virus latency, replication and phenotype of EBV-infected cells. J Pathol. 1997;182(2):151\u20139.","journal-title":"J Pathol"},{"issue":"9","key":"2694_CR123","doi-asserted-by":"publisher","first-page":"2546","DOI":"10.1172\/JCI24810","volume":"115","author":"AD Hislop","year":"2005","unstructured":"Hislop AD, Kuo M, Drake-Lee AB, Akbar AN, Bergler W, Hammerschmitt N, Khan N, Palendira U, Leese AM, Timms JM, Bell AI, Buckley CD, Rickinson AB. Tonsillar homing of Epstein\u2013Barr virus-specific CD8+ T cells and the virus-host balance. J Clin Invest. 2005;115(9):2546\u201355.","journal-title":"J Clin Invest"},{"issue":"6","key":"2694_CR124","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.1182\/blood.V98.6.1882","volume":"98","author":"Y Kasahara","year":"2001","unstructured":"Kasahara Y, Yachie A, Takei K, Kanegane C, Okada K, Ohta K, Seki H, Igarashi N, Maruhashi K, Katayama K, Katoh E, Terao G, Sakiyama Y, Koizumi S. Differential cellular targets of Epstein\u2013Barr virus (EBV) infection between acute EBV-associated hemophagocytic lymphohistiocytosis and chronic active EBV infection. Blood. 2001;98(6):1882\u20138.","journal-title":"Blood"},{"issue":"2","key":"2694_CR125","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1182\/blood.V96.2.443","volume":"96","author":"L Quintanilla-Martinez","year":"2000","unstructured":"Quintanilla-Martinez L, Kumar S, Fend F, Reyes E, Teruya-Feldstein J, Kingma DW, Sorbara L, Raffeld M, Straus SE, Jaffe ES. Fulminant EBV(+) T-cell lymphoproliferative disorder following acute\/chronic EBV infection: a distinct clinicopathologic syndrome. Blood. 2000;96(2):443\u201351.","journal-title":"Blood"},{"issue":"6","key":"2694_CR126","first-page":"1219","volume":"144","author":"IJ Su","year":"1994","unstructured":"Su IJ, Chen RL, Lin DT, Lin KS, Chen CC. Epstein\u2013Barr virus (EBV) infects T lymphocytes in childhood EBV-associated hemophagocytic syndrome in Taiwan. Am J Pathol. 1994;144(6):1219\u201325.","journal-title":"Am J Pathol"},{"issue":"32","key":"2694_CR127","doi-asserted-by":"publisher","first-page":"33019","DOI":"10.18632\/oncotarget.5028","volume":"6","author":"W Fang","year":"2015","unstructured":"Fang W, Hong S, Chen N, He X, Zhan J, Qin T, Zhou T, Hu Z, Ma Y, Zhao Y, Tian Y, Yang Y, Xue C, Tang Y, Huang Y, Zhao H, Zhang L. PD-L1 is remarkably over-expressed in EBV-associated pulmonary lymphoepithelioma-like carcinoma and related to poor disease-free survival. Oncotarget. 2015;6(32):33019\u201332.","journal-title":"Oncotarget"},{"key":"2694_CR128","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.humpath.2016.05.012","volume":"55","author":"Z Li","year":"2016","unstructured":"Li Z, Lai Y, Sun L, Zhang X, Liu R, Feng G, Zhou L, Jia L, Huang X, Kang Q, Lin D, Gao J, Shen L. PD-L1 expression is associated with massive lymphocyte infiltration and histology in gastric cancer. Hum Pathol. 2016;55:182\u20139.","journal-title":"Hum Pathol"},{"issue":"4","key":"2694_CR129","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/nri3405","volume":"13","author":"L Chen","year":"2013","unstructured":"Chen L, Flies DB. Molecular mechanisms of T cell co-stimulation and co-inhibition. Nat Rev Immunol. 2013;13(4):227\u201342.","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"2694_CR130","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s13045-016-0341-7","volume":"9","author":"XW Bi","year":"2016","unstructured":"Bi XW, Wang H, Zhang WW, Wang JH, Liu WJ, Xia ZJ, Huang HQ, Jiang WQ, Zhang YJ, Wang L. PD-L1 is upregulated by EBV-driven LMP1 through NF-\u03baB pathway and correlates with poor prognosis in natural killer\/T-cell lymphoma. J Hematol Oncol. 2016;9(1):109.","journal-title":"J Hematol Oncol"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-02694-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-025-02694-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-02694-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T06:02:29Z","timestamp":1750226549000},"score":1,"resource":{"primary":{"URL":"https:\/\/eurjmedres.biomedcentral.com\/articles\/10.1186\/s40001-025-02694-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,18]]},"references-count":130,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2694"],"URL":"https:\/\/doi.org\/10.1186\/s40001-025-02694-1","relation":{},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,18]]},"assertion":[{"value":"20 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"486"}}